Physician profile
Robert Mcdonald
NPI 1023125549
$12,555.46
in general payments reported to CMS, 2019-2025
52 companies · $2,748 in 2025
The $2,748 reported for 2025 was more than what 89% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,569 · 2020: $1,030 · 2021: $1,170 · 2022: $1,389 · 2023: $1,701 · 2024: $1,949 · 2025: $2,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,181 · Education: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,180.71 |
| Education | $216.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,787.51 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,866.48 | 2019-2025 | Tezspire, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,087.76 | 2019-2025 | Spiriva Respimat, Stiolto Respimat, Ofev |
| Takeda Pharmaceuticals U.S.A., INC. | $606.54 | 2022-2025 | Glassia |
| Amgen INC. | $589.54 | 2021-2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $546.15 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $503.10 | 2020-2025 | Dupixent |
| Genzyme Corporation | $500.31 | 2019-2025 | |
| Mylan Specialty L.P. | $458.75 | 2019-2024 | Yupelri |
| Inspire Medical Systems, INC. | $337.31 | 2023-2025 | Inspire |
| Electromed, INC. | $260.26 | 2019-2025 | Smartvest |
| Verona Pharma, INC. | $257.79 | 2025 | Ohtuvayre |
| Genentech USA, INC. | $239.27 | 2019-2025 | Xolair |
| Grifols USA, LLC | $231.31 | 2020-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $185.23 | 2024-2025 | Opsumit, Uptravi |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $157.80 | 2019-2025 | Vest Therapy Und, (O58) Sleep Respiratory Care Und |
| Insmed, INC. | $137.50 | 2019 | |
| Sunovion Pharmaceuticals INC. | $121.89 | 2019 | |
| Mallinckrodt Hospital Products INC. | $110.54 | 2020-2023 | Acthar |
| W. L. Gore & Associates, INC. | $105.54 | 2019 | |
| Medtronic, INC. | $103.16 | 2022 | |
| Pfizer INC. | $95.13 | 2022-2023 | |
| Advanced Respiratory, INC | $93.66 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $93.59 | 2019 | |
| Shire North American Group INC | $93.06 | 2019 | |
| Sanofi-Aventis U.S. LLC | $92.99 | 2025 | |
| Viatris Specialty LLC | $82.74 | 2025 | Yupelri |
| Optinose US, INC. | $76.93 | 2025 | |
| Covis Pharma Gmbh | $68.80 | 2021-2023 | |
| Boston Scientific Corporation | $46.40 | 2022 | |
| 3b Medical, INC. | $45.32 | 2025 | Luna |
| Merck Sharp & Dohme LLC | $44.12 | 2019-2023 | Keytruda |
| Phadia US INC. | $43.12 | 2019-2024 | Immunocap |
| Baxter Healthcare | $42.51 | 2024 | |
| Pulmonx Corporation | $41.66 | 2023-2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Shockwave Medical, INC | $41.03 | 2022 | |
| Alexion Pharmaceuticals, INC. | $38.24 | 2019 | |
| Abbvie INC. | $35.41 | 2024 | |
| Seqirus USA INC | $34.87 | 2019-2025 | Flucelvax, Fluad |
| Fisher & Paykel Healthcare INC | $32.08 | 2019 | |
| Csl Behring | $27.34 | 2024 | Haegarda |
| Neurocrine Biosciences, INC. | $26.03 | 2019 | |
| Vifor Pharma, INC. | $24.34 | 2024 | Zemaira |
| Janssen Pharmaceuticals, INC | $18.47 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.90 | 2021 | |
| Ani Pharmaceuticals, INC. | $16.65 | 2025 | Purified Cortrophin Gel |
| Ars Pharmaceuticals Operations, INC. | $16.46 | 2025 | Neffy |
| Circassia INC. | $16.33 | 2019 | |
| Tanabe Pharma America, INC. | $15.38 | 2019 | |
| Lilly USA, LLC | $14.45 | 2025 | Zepbound |
| Ambu INC. | $14.38 | 2024 | |
| Watermark Medical, INC. | $13.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.